FIZE Medical to Present Abstract at Critical Care Conference

Minute-by-Minute Urine Output Monitoring Predicts 30-Day Mortality in ICU Patients

Mar. 17, 2026 at 4:52pm

Got story updates? Submit your updates here. ›

FIZE Medical, a medical technology company, announced that a clinical research abstract featuring data obtained using the FIZE kUO® platform has been accepted for oral presentation at the 2026 Society of Critical Care Medicine Congress. The study demonstrates that early urine output response to furosemide, when measured digitally and continuously, is significantly associated with 30-day mortality in critically ill patients.

Why it matters

This research highlights the potential of real-time, continuous urine output monitoring to provide valuable prognostic information and support more informed fluid and hemodynamic management in the ICU setting. By leveraging high-resolution patient data, FIZE Medical aims to enable earlier detection of renal deterioration and improve personalized care for critically ill patients.

The details

The accepted abstract, titled "Minute-by-minute Measurement of Furosemide Urine Response Predicts 30-Day Mortality in ICU Patients," will be presented by Dr. Ohad Gabbay, a senior attending physician at the General Intensive Care Department at Soroka Medical Center. The study found that greater urine output response to furosemide was associated with improved 30-day survival, suggesting that real-time urine output dynamics may serve as a novel prognostic tool in critical care.

  • The presentation is scheduled for March 24, 2026 at the 2026 Society of Critical Care Medicine Congress.
  • The research was conducted as a retrospective analysis of adult ICU patients receiving intravenous furosemide.

The players

FIZE Medical

A medical technology company focused on advancing fluid management in critical care, building an AI-enabled fluid management platform to support smarter, more personalized, and proactive patient care.

Dr. Ohad Gabbay

A senior attending physician at the General Intensive Care Department at Soroka Medical Center, who will be presenting the research at the 2026 Society of Critical Care Medicine Congress.

Prof. Moti Klein

The lead investigator of the study, Chair of the Division of Anesthesiology and Intensive Care and Director of the General Intensive Care Department at Soroka Medical Center and Ben-Gurion University of the Negev, Israel.

Got photos? Submit your photos here. ›

What they’re saying

“Our findings demonstrate how real-time urine output monitoring may provide a rapid, physiologically meaningful indicator of kidney function and patient risk in the ICU”

— Prof. Moti Klein, Lead Investigator (PRNewswire)

“This research reinforces the importance of real-time and continuous UO data. These insights can support earlier recognition of patient deterioration and more informed fluid and hemodynamic management.”

— Dror Zerem, FIZE Medical (PRNewswire)

What’s next

FIZE Medical will be exhibiting the FIZE kUO® device at the 2026 Society of Critical Care Medicine Congress, where attendees can experience firsthand how continuous, automated urine output monitoring supports kidney function assessment, optimal fluid management, and hemodynamic decision-making in critically ill patients.

The takeaway

This research demonstrates the potential of real-time, continuous urine output monitoring to provide valuable prognostic information and support more personalized, data-driven care for critically ill patients in the ICU setting.